We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · September 05, 2020

Efficacy and Safety of Vedolizumab in Elderly IBD Patients

United European gastroenterology journal


Additional Info

Disclosure statements are available on the authors' profiles:

United European gastroenterology journal
Vedolizumab is Effective and Safe in Elderly Inflammatory Bowel Disease Patients: A Binational, Multicenter, Retrospective Cohort Study
United European Gastroenterol J 2020 Aug 17;[EPub Ahead of Print], NA Cohen, N Plevris, U Kopylov, A Grinman, B Ungar, H Yanai, H Leibovitzh, NF Isakov, A Hirsch, E Ritter, Y Ron, AB Shitrit, E Goldin, I Dotan, SB Horin, CW Lees, N Maharshak

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading